Plausibility, not science, has dominated public discussions of the COVID pandemic

Author:

Risch Harvey A.1ORCID

Affiliation:

1. Department of Chronic Disease Epidemiology Yale School of Public Health New Haven Connecticut USA

Abstract

AbstractCOVID‐19 put to the test the understanding of the meaning of “science” by the medical profession, the media, and the public. Unfortunately, the vast majority of individuals were misled by those who spoke on behalf of science but who confused plausible stories with scientific explanation. Scientific understanding comes from theories, which generate hypotheses, which are, in turn, confirmed or disconfirmed by empirical evidence that is evaluated using statistical methods. In our daily lives, we may judge the validity of a hypothesis based on its plausibility, and for most trivial cases that is sufficient. But it is a mistake to imagine that science can proceed on that basis. Yet, scientists themselves are often confused about the foundations of the scientific method. “Evidence‐based medicine” is now being used to discredit all medical evidence other than randomized controlled trials (RCTs), the supposed “gold standard” of medical research. This insistence on a single method that is deemed “best practice” has the ironic effect of replacing science with plausibility in medicine. RCTs fail to live up to their vaunted status because of frequent insufficiencies in randomization related to confounding errors and their magnitudes. When randomized trials were compared with observational studies in a meta‐analysis of thousands of studies, the differences in conclusions were negligible. The entire framework of COVID‐19 policy has been based on plausible hypotheses, not backed by genuine scientific evidence. Critics are correct in claiming that COVID‐19 policies have been based on politics, not science.

Publisher

Wiley

Subject

Economics and Econometrics,Sociology and Political Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3